文献速递静脉血栓栓塞慢性静脉疾病

血管内介入降低可回收下腔静脉滤器血栓风险:多中心倾向匹配分析

Endovascular Intervention Reduces Thrombosis Risk in Retrievable Inferior Vena Cava Filters: A Multicenter Propensity-Matched Analysis.
PubMed 文献 · Ann Vasc Surg · 2026-04-10

基于中国103中心2773例前瞻性注册研究,倾向匹配后比较血管内介入(EI)与无EI组,EI组滤器相关血栓/栓塞风险降低46%(8.9% vs 14.0%,P<0.001;OR=0.54,95%CI 0.41-0.71),症状性肺栓塞率无差异(1.2% vs 2.8%,P=0.07),挑战EI前常规放置滤器的必要性。

要点

  • EI与滤器相关血栓/栓塞风险降低独立相关(OR=0.54)。
  • 症状性肺栓塞发生率两组无显著差异(P=0.07)。
  • 结果支持选择性使用滤器而非EI前常规放置。

核心结论

  • EI本身降低可回收下腔静脉滤器相关血栓/栓塞风险,挑战EI前常规放置滤器的必要性。

研究设计与样本

  • 前瞻性注册研究(ChiCTR1800014252),纳入中国103中心2018-2019年2773例放置可回收下腔静脉滤器的患者。
  • 按是否接受EI分为EI组(n=1472)和无EI组(n=1301),倾向评分1:1匹配平衡23项基线变量,匹配后每组1007例。
  • 主要终点为滤器相关血栓/栓塞,由核心实验室裁定的CT/血管造影验证。

主要发现

  • 匹配后EI组滤器相关血栓/栓塞发生率为8.9%,无EI组为14.0%(P<0.001)。
  • EI与滤器相关血栓/栓塞风险降低46%相关(OR=0.54,95%CI 0.41-0.71)。
  • 症状性肺栓塞发生率两组分别为1.2%和2.8%(P=0.07)。
  • 不同品牌滤器的血栓/栓塞发生率无差异(P=0.32)。

临床怎么用

  • 对于深静脉血栓患者,血管内介入治疗本身可能降低滤器相关血栓风险,支持选择性而非常规放置可回收下腔静脉滤器。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current guidelines recommend retrievable inferior vena cava filters (RIVCFs) placement prior to endovascular intervention (EI) for deep vein thrombosis (DVT), yet the impact of EI on RIVCF-related thrombosis/trapped embolus (T/TE) remains controversial. METHODS: In this prospective registry-based study (ChiCTR1800014252), 2,773 patients undergoing RIVCF placement across 103 Chinese centers (2018-2019) were stratified into EI (n = 1,472) and no-EI (n = 1,301) groups. Propensity score matching (1:1) balanced 23 baseline variables (e.g., DVT acuity and anticoagulation). The primary end point was RIVCF T/TE (defined as inferior vena cava obstruction or thrombus >5 cm above the filter), validated by core-lab adjudicated imaging (computed tomography/angiography). All treating physicians from the 103 participating centers received unified standardized training on the clinical selection criteria for EI and non-EI therapy prior to the study initiation, ensuring consistent intercenter decision-making. The selection of therapeutic modalities was further based on individualized clinical characteristics, including the anatomical location of DVT, thrombus burden, presence of procedural contraindications, and patient's informed consent after full risk-benefit explanation. RESULTS: After matching (n = 1,007 per group), EI was associated with a 46% lower risk of RIVCF T/TE (8.9% vs. 14.0%, P < 0.001; odds ratio = 0.54, 95% confidence interval: 0.41-0.71). Symptomatic pulmonary embolism rates were comparable (1.2% vs. 2.8%, P = 0.07). No brand-specific differences in T/TE incidence were observed (P = 0.32). CONCLUSION: This study challenges the necessity of routine RIVCF placement before EI, demonstrating that EI itself reduces thrombosis risk. These findings advocate for selective filter use, potentially sparing patients from device-related complications.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wang XN, Zhang H, Li XY, et al. Endovascular Intervention Reduces Thrombosis Risk in Retrievable Inferior Vena Cava Filters: A Multicenter Propensity-Matched Analysis. Ann Vasc Surg. 2026. PMID: 41967669. doi:10.1016/j.avsg.2026.03.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。